Pleiotropic cellular, hemostatic, and biological actions of Ankaferd hemostat

被引:55
作者
Haznedaroglu, Berat Z. [2 ]
Beyazit, Yavuz [1 ]
Walker, Sharon L. [3 ]
Haznedaroglu, Ibrahim C. [4 ]
机构
[1] Turkiye Yuksek Ihtisas Hosp, Dept Gastroenterol, TR-06100 Ankara, Turkey
[2] Yale Univ, Dept Chem & Environm Engn, New Haven, CT 06511 USA
[3] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA
[4] Hacettepe Univ, Fac Med, Dept Hematol, TR-06100 Ankara, Turkey
关键词
Ankaferd Blood Stopper; Hemostasis; Hemostatic agent; Hemorrhagic diathesis; Antineoplastic; CONTROLLED CLINICAL-TRIAL; BLOOD STOPPER; IN-VITRO; AGENT; EFFICACY; MANAGEMENT; BLOODSTOPPER; HEMORRHAGE; PATIENT; MODEL;
D O I
10.1016/j.critrevonc.2011.10.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sustaining hemostasis in clinical hemorrhages is a challenging task and requires extensive effort to stabilize medically hard-to-treat traumatic injuries. Several hemostatic agents are preferred to control external and internal bleedings, yet commercially available products are not sufficiently effective or fast-acting to achieve hemostasis in extreme cases. Anlcaferd Blood Stopper (ABS) is a herbal extract traditionally used as a hemostatic agent. Recent studies have shown that ABS could be utilized successfully as a hemostatic agent for the management of clinical hemorrhages when conventional methods were ineffective. This review serves as a basis to provide recent findings on several applications of ABS, specifically preclinical, biological, and clinical studies both in vitro and in vivo. Another section focuses on the ultrastructural morphology and protein network formation of ABS in an effort to understand the hemostatic mechanisms of this unique agent at tissue level. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:21 / 34
页数:14
相关论文
共 74 条
  • [1] Akgul T, 2009, UHOD-ULUSLAR HEMATOL, V19, P159
  • [2] Akkoç N, 2009, TURK KLIN TIP BILIM, V29, P410
  • [3] Aktas A, 2010, UHOD-ULUSLAR HEMATOL, V20, P156
  • [4] Al B, 2009, SAUDI MED J, V30, P1520
  • [5] Albayrak CU, 2008, J INT MED RES, V36, P1447
  • [6] Arslan S., 2009, Resp Med CME, V2, P144, DOI DOI 10.1016/J.RMEDC.2008.10.016
  • [7] Aydin S, 2009, J INT MED RES, V37, P279
  • [8] Balcik OS, 2010, INT J LAB HEM S1, V32, P126
  • [9] Baykul Timucin, 2010, J Contemp Dent Pract, V11, pE088
  • [10] Beyazit Y, 2010, ALTERN MED REV, V15, P329